世界の子癇前症診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preeclampsia Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5315 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、子癇前症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液検査、尿検査）、用途別市場規模（病院、専門クリニック、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・子癇前症診断の市場動向 ・企業の競争状況、市場シェア ・子癇前症診断の種類別市場規模と予測2016-2027（血液検査、尿検査） ・子癇前症診断の用途別市場規模と予測2016-2027（病院、専門クリニック、診断センター、その他） ・子癇前症診断の北米市場規模2016-2027（アメリカ、カナダ） ・子癇前症診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・子癇前症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子癇前症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・子癇前症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、PerkinElmer、DRG INSTRUMENTS GMBH、Thermo Fisher Scientific、Diabetomics, Inc.、Metabolomic Diagnostics Ltd.、Sera Prognostics、Siemens Healthineers、Bayer） ・結論

Preeclampsia, a rapidly progressive disorder is characterized by elevated blood pressure and excessive protein in the urine of pregnant women.

Market Analysis and Insights: Global Preeclampsia Diagnostic Market
The global Preeclampsia Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preeclampsia Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preeclampsia Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preeclampsia Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preeclampsia Diagnostic market.

Global Preeclampsia Diagnostic Scope and Market Size
Preeclampsia Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preeclampsia Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Tests
Urine Analysis

Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
PerkinElmer
DRG INSTRUMENTS GMBH
Thermo Fisher Scientific
Diabetomics, Inc.
Metabolomic Diagnostics Ltd.
Sera Prognostics
Siemens Healthineers
Bayer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preeclampsia Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Tests
1.2.3 Urine Analysis
1.3 Market by Application
1.3.1 Global Preeclampsia Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preeclampsia Diagnostic Market Perspective (2016-2027)
2.2 Preeclampsia Diagnostic Growth Trends by Regions
2.2.1 Preeclampsia Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preeclampsia Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Preeclampsia Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Preeclampsia Diagnostic Industry Dynamic
2.3.1 Preeclampsia Diagnostic Market Trends
2.3.2 Preeclampsia Diagnostic Market Drivers
2.3.3 Preeclampsia Diagnostic Market Challenges
2.3.4 Preeclampsia Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preeclampsia Diagnostic Players by Revenue
3.1.1 Global Top Preeclampsia Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Preeclampsia Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Preeclampsia Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preeclampsia Diagnostic Revenue
3.4 Global Preeclampsia Diagnostic Market Concentration Ratio
3.4.1 Global Preeclampsia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preeclampsia Diagnostic Revenue in 2020
3.5 Preeclampsia Diagnostic Key Players Head office and Area Served
3.6 Key Players Preeclampsia Diagnostic Product Solution and Service
3.7 Date of Enter into Preeclampsia Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preeclampsia Diagnostic Breakdown Data by Type
4.1 Global Preeclampsia Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Preeclampsia Diagnostic Forecasted Market Size by Type (2022-2027)

5 Preeclampsia Diagnostic Breakdown Data by Application
5.1 Global Preeclampsia Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Preeclampsia Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preeclampsia Diagnostic Market Size (2016-2027)
6.2 North America Preeclampsia Diagnostic Market Size by Type
6.2.1 North America Preeclampsia Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Preeclampsia Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Preeclampsia Diagnostic Market Size by Type (2016-2027)
6.3 North America Preeclampsia Diagnostic Market Size by Application
6.3.1 North America Preeclampsia Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Preeclampsia Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Preeclampsia Diagnostic Market Size by Application (2016-2027)
6.4 North America Preeclampsia Diagnostic Market Size by Country
6.4.1 North America Preeclampsia Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Preeclampsia Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Preeclampsia Diagnostic Market Size (2016-2027)
7.2 Europe Preeclampsia Diagnostic Market Size by Type
7.2.1 Europe Preeclampsia Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Preeclampsia Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Preeclampsia Diagnostic Market Size by Type (2016-2027)
7.3 Europe Preeclampsia Diagnostic Market Size by Application
7.3.1 Europe Preeclampsia Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Preeclampsia Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Preeclampsia Diagnostic Market Size by Application (2016-2027)
7.4 Europe Preeclampsia Diagnostic Market Size by Country
7.4.1 Europe Preeclampsia Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Preeclampsia Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preeclampsia Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Preeclampsia Diagnostic Market Size by Type
8.2.1 Asia-Pacific Preeclampsia Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preeclampsia Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preeclampsia Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Preeclampsia Diagnostic Market Size by Application
8.3.1 Asia-Pacific Preeclampsia Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preeclampsia Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preeclampsia Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Preeclampsia Diagnostic Market Size by Region
8.4.1 Asia-Pacific Preeclampsia Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preeclampsia Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preeclampsia Diagnostic Market Size (2016-2027)
9.2 Latin America Preeclampsia Diagnostic Market Size by Type
9.2.1 Latin America Preeclampsia Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Preeclampsia Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Preeclampsia Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Preeclampsia Diagnostic Market Size by Application
9.3.1 Latin America Preeclampsia Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Preeclampsia Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Preeclampsia Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Preeclampsia Diagnostic Market Size by Country
9.4.1 Latin America Preeclampsia Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Preeclampsia Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preeclampsia Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Preeclampsia Diagnostic Market Size by Type
10.2.1 Middle East & Africa Preeclampsia Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preeclampsia Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preeclampsia Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Preeclampsia Diagnostic Market Size by Application
10.3.1 Middle East & Africa Preeclampsia Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preeclampsia Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preeclampsia Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Preeclampsia Diagnostic Market Size by Country
10.4.1 Middle East & Africa Preeclampsia Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preeclampsia Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Preeclampsia Diagnostic Introduction
11.1.4 Roche Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.1.5 Roche Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Preeclampsia Diagnostic Introduction
11.2.4 PerkinElmer Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.2.5 PerkinElmer Recent Development
11.3 DRG INSTRUMENTS GMBH
11.3.1 DRG INSTRUMENTS GMBH Company Details
11.3.2 DRG INSTRUMENTS GMBH Business Overview
11.3.3 DRG INSTRUMENTS GMBH Preeclampsia Diagnostic Introduction
11.3.4 DRG INSTRUMENTS GMBH Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.3.5 DRG INSTRUMENTS GMBH Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Preeclampsia Diagnostic Introduction
11.4.4 Thermo Fisher Scientific Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Diabetomics, Inc.
11.5.1 Diabetomics, Inc. Company Details
11.5.2 Diabetomics, Inc. Business Overview
11.5.3 Diabetomics, Inc. Preeclampsia Diagnostic Introduction
11.5.4 Diabetomics, Inc. Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.5.5 Diabetomics, Inc. Recent Development
11.6 Metabolomic Diagnostics Ltd.
11.6.1 Metabolomic Diagnostics Ltd. Company Details
11.6.2 Metabolomic Diagnostics Ltd. Business Overview
11.6.3 Metabolomic Diagnostics Ltd. Preeclampsia Diagnostic Introduction
11.6.4 Metabolomic Diagnostics Ltd. Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.6.5 Metabolomic Diagnostics Ltd. Recent Development
11.7 Sera Prognostics
11.7.1 Sera Prognostics Company Details
11.7.2 Sera Prognostics Business Overview
11.7.3 Sera Prognostics Preeclampsia Diagnostic Introduction
11.7.4 Sera Prognostics Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.7.5 Sera Prognostics Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Details
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers Preeclampsia Diagnostic Introduction
11.8.4 Siemens Healthineers Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.8.5 Siemens Healthineers Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Preeclampsia Diagnostic Introduction
11.9.4 Bayer Revenue in Preeclampsia Diagnostic Business (2016-2021)
11.9.5 Bayer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preeclampsia Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Tests
Table 3. Key Players of Urine Analysis
Table 4. Global Preeclampsia Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Preeclampsia Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Preeclampsia Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Preeclampsia Diagnostic Market Share by Regions (2016-2021)
Table 8. Global Preeclampsia Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Preeclampsia Diagnostic Market Share by Regions (2022-2027)
Table 10. Preeclampsia Diagnostic Market Trends
Table 11. Preeclampsia Diagnostic Market Drivers
Table 12. Preeclampsia Diagnostic Market Challenges
Table 13. Preeclampsia Diagnostic Market Restraints
Table 14. Global Preeclampsia Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Preeclampsia Diagnostic Market Share by Players (2016-2021)
Table 16. Global Top Preeclampsia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preeclampsia Diagnostic as of 2020)
Table 17. Ranking of Global Top Preeclampsia Diagnostic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Preeclampsia Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Preeclampsia Diagnostic Product Solution and Service
Table 21. Date of Enter into Preeclampsia Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Preeclampsia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Preeclampsia Diagnostic Revenue Market Share by Type (2016-2021)
Table 25. Global Preeclampsia Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Preeclampsia Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Preeclampsia Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Preeclampsia Diagnostic Revenue Market Share by Application (2016-2021)
Table 29. Global Preeclampsia Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Preeclampsia Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Preeclampsia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Preeclampsia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Preeclampsia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Preeclampsia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Preeclampsia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Preeclampsia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Preeclampsia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Preeclampsia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Preeclampsia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Preeclampsia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Preeclampsia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Preeclampsia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Preeclampsia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Preeclampsia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Preeclampsia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Preeclampsia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Preeclampsia Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Preeclampsia Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Preeclampsia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Preeclampsia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Preeclampsia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Preeclampsia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Preeclampsia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Preeclampsia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Preeclampsia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Preeclampsia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Preeclampsia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Preeclampsia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Preeclampsia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Preeclampsia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Preeclampsia Diagnostic Product
Table 64. Roche Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. PerkinElmer Company Details
Table 67. PerkinElmer Business Overview
Table 68. PerkinElmer Preeclampsia Diagnostic Product
Table 69. PerkinElmer Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 70. PerkinElmer Recent Development
Table 71. DRG INSTRUMENTS GMBH Company Details
Table 72. DRG INSTRUMENTS GMBH Business Overview
Table 73. DRG INSTRUMENTS GMBH Preeclampsia Diagnostic Product
Table 74. DRG INSTRUMENTS GMBH Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 75. DRG INSTRUMENTS GMBH Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Preeclampsia Diagnostic Product
Table 79. Thermo Fisher Scientific Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Diabetomics, Inc. Company Details
Table 82. Diabetomics, Inc. Business Overview
Table 83. Diabetomics, Inc. Preeclampsia Diagnostic Product
Table 84. Diabetomics, Inc. Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 85. Diabetomics, Inc. Recent Development
Table 86. Metabolomic Diagnostics Ltd. Company Details
Table 87. Metabolomic Diagnostics Ltd. Business Overview
Table 88. Metabolomic Diagnostics Ltd. Preeclampsia Diagnostic Product
Table 89. Metabolomic Diagnostics Ltd. Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 90. Metabolomic Diagnostics Ltd. Recent Development
Table 91. Sera Prognostics Company Details
Table 92. Sera Prognostics Business Overview
Table 93. Sera Prognostics Preeclampsia Diagnostic Product
Table 94. Sera Prognostics Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 95. Sera Prognostics Recent Development
Table 96. Siemens Healthineers Company Details
Table 97. Siemens Healthineers Business Overview
Table 98. Siemens Healthineers Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 99. Siemens Healthineers Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Preeclampsia Diagnostic Product
Table 103. Bayer Revenue in Preeclampsia Diagnostic Business (2016-2021) & (US$ Million)
Table 104. Bayer Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preeclampsia Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Blood Tests Features
Figure 3. Urine Analysis Features
Figure 4. Global Preeclampsia Diagnostic Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Preeclampsia Diagnostic Report Years Considered
Figure 10. Global Preeclampsia Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Preeclampsia Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Preeclampsia Diagnostic Market Share by Regions: 2020 VS 2027
Figure 13. Global Preeclampsia Diagnostic Market Share by Regions (2022-2027)
Figure 14. Global Preeclampsia Diagnostic Market Share by Players in 2020
Figure 15. Global Top Preeclampsia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preeclampsia Diagnostic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Preeclampsia Diagnostic Revenue in 2020
Figure 17. Global Preeclampsia Diagnostic Revenue Market Share by Type (2016-2021)
Figure 18. Global Preeclampsia Diagnostic Revenue Market Share by Type (2022-2027)
Figure 19. North America Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Preeclampsia Diagnostic Market Share by Type (2016-2027)
Figure 21. North America Preeclampsia Diagnostic Market Share by Application (2016-2027)
Figure 22. North America Preeclampsia Diagnostic Market Share by Country (2016-2027)
Figure 23. United States Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Preeclampsia Diagnostic Market Share by Type (2016-2027)
Figure 27. Europe Preeclampsia Diagnostic Market Share by Application (2016-2027)
Figure 28. Europe Preeclampsia Diagnostic Market Share by Country (2016-2027)
Figure 29. Germany Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Preeclampsia Diagnostic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Preeclampsia Diagnostic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Preeclampsia Diagnostic Market Share by Region (2016-2027)
Figure 39. China Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Preeclampsia Diagnostic Market Share by Type (2016-2027)
Figure 47. Latin America Preeclampsia Diagnostic Market Share by Application (2016-2027)
Figure 48. Latin America Preeclampsia Diagnostic Market Share by Country (2016-2027)
Figure 49. Mexico Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Preeclampsia Diagnostic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Preeclampsia Diagnostic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Preeclampsia Diagnostic Market Share by Country (2016-2027)
Figure 55. Turkey Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Preeclampsia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 59. PerkinElmer Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 60. DRG INSTRUMENTS GMBH Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 62. Diabetomics, Inc. Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 63. Metabolomic Diagnostics Ltd. Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 64. Sera Prognostics Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 65. Siemens Healthineers Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Preeclampsia Diagnostic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---